We have developed a model of reperfusion injury in Krebs buffer-perfused rabbit lungs, characterized by pulmonary vasoconstriction, microvascular injury, and marked lung edema formation. During reperfusion there was a threefold increase in lung superoxide anion (0°) production, as measured by in vivo reduction of nitroblue tetrazolium, and a twofold increase in the release of 02 into lung perfusate, as measured by reduction of succinylated ferricytochrome c. Injury could be prevented by the xanthine oxidase inhibitor allopurinol, the 02 scavenger SOD, the hydrogen peroxide scavenger catalase, the iron chelator deferoxamine, or the thiols dimethylthiourea or Nacetylcysteine. The protective effect of SOD could be abolished by the anion channel blocker 4,4'-diisothiocyano-2,2'-stilbene disulfonic acid, indicating that SOD consumes 02 in the extracellular medium, thereby creating a concentration gradient favorable for rapid diffusion of 02 out of cells. Our results extend information about the mechanisms of reperfusion lung injury that have been assembled by studies in other organs, and offer potential strategies for improved organ preservation, for treatment of reperfusion injury after pulmonary thromboembolectomy, and for explanation and therapy of many complications of pulmonary embolism.
Introduction
Free radical-mediated injury is a major cause of damage occurnng in ischemic tissue after reperfusion (1) . Currently, reperfusion injury is thought to hinge on two critical events occurring during ischemia: degradation of cellular stores of ATP to the purines hypoxanthine and xanthine; and conversion of xanthine dehydrogenase to xanthine oxidase (1) . Dur- ing reperfusion, the sudden availability of oxygen to act as cofactor allows xanthine oxidase to convert purine substrate accumulated during ischemia to uric acid, with byproduct formation of superoxide anions (O2) and hydrogen peroxide (H202) (1, 2) . In the presence of iron, 02 and H202 can participate in an 05-driven Fenton reaction to produce hydroxyl radicals (OH) (3):
Hydroxyl radicals are potent oxidants that cause tissue injury by initiating lipid peroxidation of cell membranes and oxidative inactivation of critical cell proteins (3) . During reperfusion, the above reactions can be stopped and injury prevented by inhibiting xanthine oxidase to prevent production of O2 and H202 (1) , scavenging O2 to prevent its reduction of iron (1, 4) , chelating iron so that it is unavailable to participate in the generation of * OH (5), or neutralizing * OH with scavenging reagents (6) .
Reperfusion injury mediated by oxygen free radicals has been reported in heart (7), brain (5), intestine (8) , liver (9) , pancreas (10) , kidney (6) , and skin (11) . Whereas reperfusion injury has also been reported after reexpansion of atelectatic lung (12) or reperfusion of a mechanically occluded pulmonary artery ( 13) , investigators have generally felt that the lung is relatively immune from reperfusion injury because oxidative metabolism does not decrease and ATP levels do not fall until alveolar Po2 drops below 1 mmHg (14) . We undertook this investigation to characterize the biochemical events during reperfusion lung injury after warm ischemia. Our results indicate that the lung is susceptible to reperfusion injury. The source ofthis injury appears to be reactive oxygen species, such as O°generated during reperfusion. Our experiments also show that extracellular SOD protects against intracellular damage from toxic oxygen species by consuming O°in the extracellular medium, thereby promoting rapid concentration-driven diffusion of O°out of the intracellular compartment.
Methods
Reagents and pharmaceuticals. N-Acetylcysteine, allopurinol, 3,000 U/mg catalase from bovine liver, diethyldithiocarbamate (DDC), ' 4,4'-diisothiocyano-2,2'-stilbene disulfonic acid (DIDS), N-ethylmaleimide (NEM), FeCl3, ferricytochrome c (type VI horse heart), indomethacin, nitroblue tetrazolium (NBT), 3,200 U/mg SOD from bovine erythrocytes, and succinic anhydride were obtained from Sigma Chemical Company, St. Louis, MO. Dimethylthiourea (DMTU) was obtained from Fike Chemicals, Nitro, WV. Deferoxamine mesylate (Desferal) was obtained from Ciba-Geigy Pharmaceuticals, Summit, NJ. Reagent grade pyridine was from Fisher Chemical Company, Fair Lawn, NJ. Lung perfusion technique. Male New Zealand white rabbits (Myrtle Farms, Nashville, TN) weighing 2.5-3 kg were maintained on rabbit formula (18; Carnation Co., Los Angeles, CA) and water ad lib. On the day ofthe experiment, the rabbits were given 3,000 U ofheparin by ear vein and anesthetized with 25 mg/kg sodium pentobarbital. The chest was opened and the animal killed by rapid exsanguination from the left ventricle. Right and left parasternal incisions were made along the costal cartilages to remove the sternum and open the chest widely. Stainless steel cannulae were secured in the left atrium and pulmonary artery with umbilical tape. The ligature around the pulmonary artery was also passed around the aorta, preventing loss of perfusate into the systemic circulation. The pulmonary circulation was washed free of blood with -500 ml of perfusate before recirculating flow was established at 50 ml/min. The perfusate medium was protein-free KrebsHenseleit buffer (15) prepared with deionized water and maintained at a temperature of 37-380C and pH of 7.35-7.40.
The perfusion circuit included a perfusate reservoir, roller perfusion pump (Sarns, Inc., Ann Arbor, MI), filter (swank transfusion filter; Extracorporeal Medical Specialties, Inc., King of Prussia, PA), and heat exchanger, connected by Tygon tubing. The reservoir collecting perfusate from the left atrium was suspended from a force displacement transducer (model FTlOD; Grass Instrument Company, Quincy, MA) so that loss of reservoir weight from lung edema formation could be continuously measured. The perfusate reservoir was placed below the lower most portion of the lung to keep left atrial pressure at zero. The volume of the perfusion system was 250 ml.
The lungs were ventilated with 5% CO2 in air through a tracheostomy using an animal respirator (Harvard Apparatus Company, Inc., S. Natick, MA) delivering a tidal volume of 7 ml/kg at 18 breaths per minute with 2 cm H20 positive end-expiratory pressure. Pulmonary arterial, left atrial, and tracheal pressures were monitored using pressure transducers (P23ID; Gould Statham Instruments, Inc., Hato Rey, PR) connected to the inflow circulation, outflow circulation, and tracheal cannula. Pressure and force transducer measurements were recorded on a four-channel recorder (model 2400S; Gould Statham Instruments, Inc.). Successful preparations with initial pulmonary artery pressures between 8 and 15 mmHg and weight gain at rates of < 0.2 g/min are achieved in > 90% of rabbit lungs (16) . Lungs can be perfused in this manner for up to 60 min.
Lung perfusion protocols. After surgery, lungs were perfused for 5 min to ensure integrity of the preparation, as measured by normal pressures and negligible weight gain. Ventilation and perfusion were then stopped and the lungs were covered with moist gauze sponges to prevent dessication. The preparation was thereafter allowed to equilibrate to room temperature (250C), a process usually requiring 30 min. After a 3-h interval ofischemia (usually 4 h from the point ofexsanguination of the animal), ventilation was reinstated, initially at a tidal volume of 14 ml/kg to open atelectatic lung, then at the original tidal volume of 7 ml/kg. Perfusion was then reinstated at 10 ml/min with increments of 5 ml/min every 15 s until the original flow of 50 ml/min was achieved. Perfusion was continued for 10 min to determine the effect of reventilation and reperfusion on pulmonary artery and tracheal pressures, and on lung weight gain from edema formation.
In selected experiments, the interval of ischemia was shortened from 3 to 2.5 h in an effort to decrease the severity ofreperfusion injury and lengthen the time that reperfused lungs could be studied.
Pharmacologic interventions. Control lungs were perfused without treatment. Additional groups of lungs were perfused with one of the following interventional additions to the perfusate: the cyclooxygenase inhibitor ofarachidonate metabolism indomethacin (16) ; the xanthine oxidase inhibitor allopurinol (1, 2) ; the antioxidant enzymes SOD and catalase (CAT) (1, 4) ; the iron chelator deferoxamine (17) ; and the thiols DMTU (18) or N-acetylcysteine (19) . Allopurinol and DMTU were added to perfusate before surgical preparation so that blood was washed from the lung with buffer containing these agents. SOD and catalase were injected into the pulmonary artery just before reventilation and reperfusion. The remaining agents were added to the perfusate reservoir at the beginning of the baseline perfusion period.
Controls to enhance specificity of the pharmacologic probes included perfusing groups of lungs in which inactivated SOD, inactivated catalase, iron-saturated deferoxamine, or derivatized DMTU were added to the perfusate. SOD was inactivated by incubation with DDC to chelate the enzyme's copper, followed by dialysis against normal saline to remove the DDC-copper complex before use (20) . Catalase was inactivated by boiling. Deferoxamine was iron saturated by incubation in 10 ml 0.9% NaCl with FeCl3 (8.5 parts by weight of Fe3+ to 100 parts of deferoxamine). DMTU was derivatized by incubation with slightly less than a half-molar equivalent of the alkylating agent NEM in 10 ml 0.9% NaCl for 30 min with gentle agitation. Unreacted NEM was removed by passing the mixture over a Sep-Pak column (C-18; Waters Associates Millipore Corp., Milford, MA) before adding inactivated DMTU to lung perfusate.
Measurement of in vivo superoxide production in ventilated and perfused lungs. In vivo O°production by ventilated and perfused lung was measured by two techniques. The first technique assessed intracellular O°by a modification of the method of Kontos for measuring cerebral O2 production (21) . Detection ofO°by this method relies on reduction of NBT to form insoluble formazan. Lungs were perfused with 300 ItM NBT added to the reservoir at the beginning of baseline perfusion for measurement of O°production in reperfused lungs. As NBT was reduced, the lungs became tinted a deep purple. After 10 min of perfusion, lungs were quickly dissected free from the thorax. Wet and dry weight were obtained for one lung before and after drying for 72 h at 60C for determination ofwet/dry weight ratio. A 0.5-g sample of the remaining lung was homogenized in cold (40C) normal saline, and centrifuged in the cold at 10,000 g for 10 min. The pellet was resuspended in 5 ml of reagent grade pyridine and placed in a heating block (Lab-Line Instruments, Melrose Park, IL) at 850C for 4 h to extract formazan. The tube was then centrifuged at 10,000 gfor 10 min and the supernatant containing pyridine was removed and evaporated under nitrogen. The residue containing the reduced NBT was redissolved in 2 ml pyridine. Absorbance of 1 ml of the solution was measured at 550 nm with a spectrophotometer (Gilford Instrument Laboratories, Inc., Oberlin, OH) and the amount of NBT reduced was determined based on an extinction coefficient of 1.5 X 104 M-' . cm-1 (22) and corrected for grams dry weight of lung/minute.
A second technique was used to measure O°release into lung perfusate by SOD-inhibitable reduction of succinylated ferricytochrome c. Succinylated ferricytochrome c was used as an indicating scavenger instead of native ferricytochrome c to decrease interference from competing reductase reactions in biological systems (23). Type VI horse heart ferricytochrome c was partially succinylated by the method of Kuthan et al. (23). Finely grained succinic anhydride (15.9 mmol) was added to a vigorously stirred cold (4°C) solution of ferricytochrome c (300 Mmol) in 1,500 ml of potassium phosphate buffer (0.03 M) over 30 min. The pH of the solution was kept at 7.6 by titration with 2 M potassium hydroxide. The solution was stirred for an additional 20 min, dialyzed against double-distilled deionized water for 24 h, and lyophilized. Succinylated cytochrome c was stored at -70°C before use. The preparation had 38% of the trinitrobenzenesulfonic acid (TNBS) reactive amine groups ofthe cytochrome c molecule (24) .
O°was measured in perfusate by adding 60 AM succinylated ferricytochrome c to the reservoirjust before reventilation and reperfusion. After restoration of flow to 50 ml/min, 2-ml samples of perfusate were withdrawn from the outflow cannula at timed intervals of 1, 2.5, 5, 7.5, and 10 min of perfusion. Samples were centrifuged at 1,000 g for 10 min to remove debris, and perfusate absorbance was determined at 550 nm. The change in absorbance between each timed sample and that of 60 MM succinylated ferricytochrome c in unperfused buffer was used with an extinction coefficient of2.1 X 104 M-' *cm-' (23) to determine ferricytochrome c reduction.
Experiments with anion channel blockade. To gain further insight into the origin of°2 in reperfusion injury, lungs were perfused with the anion channel blocker DIDS (100 MM) added to the reservoir during baseline perfusion. The exchange of monovalent anions through cell membranes is mediated by the large transmembrane protein known as band 3 protein (25) . Charged O°radicals have been previously shown to pass freely through cell membranes via this anion channel (26). DIDS is a reversible specific blocker ofthe anion channel (27) and was given to prevent intracellular°2 formed during reventilation and reperfusion from exiting into the extracellular medium. The DIDS-treated lungs were subsequently reperfused with active SOD, without SOD, or with 1.5 mM allopurinol added to perfusate as described above. All DIDS-perfused lungs were studied in a darkened room to prevent photolytic decomposition of DIDS.
Statistical analysis. Values for pulmonary artery pressure (PP), maximal inspiratory tracheal pressure (PT, as measured from functional residual capacity), cumulative lung weight gain, and ferricytochrome c reduction among experimental groups were analyzed by two-way analysis of variance with randomized split-block design (28) . Rates oflung weight gain (AW) and NBT reduction among experimental groups were analyzed by one-way analysis of variance (29) . Comparisons among groups were performed with Duncan's multiple range test (30) . Significance was assumed when P < 0.05. Values are reported as mean±SEM.
Results
Characterization of the model. Fig. 1 shows a typical experiment in an untreated control lung. During 5 min of baseline perfusion, pulmonary artery and tracheal pressures remained normal, and there was negligible weight gain. After 3 h of ischemia, reventilation and reperfusion of untreated control lungs resulted in marked pulmonary edema, characterized by elevations in Ppa, PT, and AW. Ppa rose to a maximum (Ppmam = 30±2 mmHg, P < 0.001 compared with baseline) while flow was being increased back to 50 ml/min. Thereafter, Pp. slowly fell, but remained elevated above baseline level. PT and AW also increased significantly during the 10 min of reperfusion (PT = to 24±4 mmHg, AW to 3.62±0.76 g/min, P < 0.001 compared with baseline). By the end ofreperfusion, this preparation and all other untreated control lungs were obviously edematous, with frothy fluid filling the tracheal cannula. The rise in Pp. during reperfusion was prevented by adding 5 ,g/ml of the cyclooxygenase inhibitor indomethacin to the perfusate (Fig. 2) . However, indomethacin did not prevent the increase in PT (17±3.5 mmHg) and AW (3.20±1.50 g/min), or the development of pulmonary edema during reperfusion. This suggests that edema formation during reventilation and reperfusion is due not only to a rise in perfusion pressure, but is also (16, 31) . When the duration of ischemia was shortened to 2.5 h to lengthen the time lungs could be studied, untreated reperfused lungs (Table I) did not experience the profound rise in Pp. that had been observed in the 3-h ischemia group. Nonetheless, untreated reperfused lungs in these experiments gained more weight than normal nonreperfused lungs (1.52±0.36 g/min compared with 0.11±0.02 g/min in nonreperfused lungs, P < 0.05).
Effects of antioxidant interventions. In view of the central role of xanthine oxidase as the enzymatic origin of reactive oxygen species in reperfusion injury of other organs (1, 2), we critically evaluated the effects of an inhibitor of xanthine oxidase on lung injury in our model. Fig. 3 shows that pretreatment of lungs with the xanthine oxidase inhibitor allopurinol (1.5 mM), prevents lung injury after reventilation and reperfusion. Ppl PT, and AW from treated groups were all significantly lower than in untreated controls. Because allopurinol has been demonstrated to show scavenging activity for * OH (32), we also performed experiments with lower concentrations (100 ,gM) to enhance specificity of the probe for inhibiting xanthine oxidase. This lower concentration also prevented lung injury after reventilation and reperfusion (Fig. 3) . Support for oxidant-mediated injury in this model was provided by pretreatment with the antioxidant enzymes SOD (25,000 U) or CAT (50,000 U). Results of pretreatment of lungs with SOD just before reventilation and reperfusion are shown in Fig. 4 . Active SOD prevented lung injury, as measured by Pp. and AW. The values for PT were lower in SODtreated lungs at a level of significance of P = 0.06. Inactivated SOD failed to prevent lung edema, as measured AW and PT.
Ppa was lower, however, in lungs treated with inactivated SOD than in untreated control lungs. The reason for differences in Ppa between the inactive SOD-treated group and control reperfused lungs is not apparent at this time and will require further investigation. The effect ofcatalase on reperfusion lung injury was studied using a 2.5-h period of ischemia. Catalase provided significant protection from reperfusion injury, with a cumulative lung weight gain that was one-third that of untreated reperfused lungs (Fig. 5) . PT was also significantly lower in CAT-treated lungs (Table I ). All catalase treated lungs were successfully reperfused for a full 30 min, whereas some of the untreated ischemic lungs could not be reperfused that long because ofextensive edema formation, with cumulative weight gains of almost 50 g. Inactivated catalase failed to protect two lungs from reperfusion injury (cumulative lung weight gains of 18 and 25 g, respectively, over 30 min). To our surprise, Pp.
was significantly higher in catalase treated reperfused lungs (Table I ) than in either nonreperfused or untreated reperfused lungs. The reason for this observation is presently not clear.
The protective effects of either SOD or catalase suggested that an Os-driven Fenton reaction may be responsible for lung injury in this model. Fig. 6 shows that pretreatment of lungs with the iron chelator deferoxamine (10 mM), or the thiols DMTU (45 mM) or N-acetylcysteine (5 mM), prevents lung injury after reventilation and reperfusion. Pp,, PT, and AW from treated groups were all significantly lower than in untreated controls. Because deferoxamine (33) has been demonstrated to show scavenging activity for -OH, we also performed experiments with lower concentrations of this agent (100 guM) to enhance its specificity as a probe for chelating iron. This lower concentration ofdeferoxamine also prevented lung injury after reperfusion and reventilation (AW = 0.24±0.10 g/min for five lungs, P < 0.001 compared with untreated reperfused lungs). Iron-saturated deferoxamine (10 mM) did not protect from reperfusion injury (AW = 0 g/min during baseline; 3.83±1.31 g/min during reperfusion). Lungs reperfused with derivatized DMTU (45 mM) gained no weight during baseline (AW = 0 g/min) but developed edema (AW = 30.5±0.50 g/min) during reperfusion that was significantly worse than in untreated reperfused lungs (P < 0.05).
In vivo measurements of02 release. To better characterize the role of reactive oxygen species in reperfusion lung injury, we measured in vivo lung O°generation by reduction of NBT or succinylated ferricytochrome c. As shown in Fig. 7 , nonreperfused lungs reduced 61±12 Mmol NBT/g dry lung per min. The NBT reduction that occurred during baseline was not inhibited by SOD and is probably best explained by the ability of metabolizing cells to also reduce NBT by NADH and NADPH reductases, so that only a portion of NBT is reduced by Os-dependent mechanisms (22) . During reperfusion, reduction rose more than threefold to 208±35 ,umol NBT/g dry lung per min (P < 0.001 compared with nonreperfused lungs). When SOD was injected into the pulmonary artery prior to reventilation and reperfusion, the rise in NBT reduction that occurred during reperfusion was blocked (64±3 ,mol NBT/g dry lung per min, P < 0.05 compared with untreated reperfused lungs, but not significantly different from nonreperfused lungs). Allopurinol (1.5 mM) also decreased NBT reduction compared with that in untreated reperfused lungs (124±16 ,gmol NBT reduced/g dry lung per min, P < 0.05), but reduction was still twice that of nonreperfused controls. Fig. 8 shows results of in vivo O°generation measured by reduction of succinylated ferricytochrome c in perfusate over 10 min. Reduction occurred in uninjured nonreperfused lungs, but did not increase substantially over time and was inhibited only slightly by SOD. In contrast, reduction of succinylated ferricytochrome c was significantly higher in reperfused lungs (P < 0.001 compared with uninjured nonreperfused lungs), increased over the course of 10 min (0.41±0.05 uM/min), and was significantly inhibited by SOD back to levels of reduction observed in uninjured control lungs (P < 0.001 for SOD reperfused lungs compared with lungs reperfused without SOD).2 This constitutes evidence for increased ' Sbpurwond US MM DIDS decreased reduction of cytochrome c to levels lower than in nonreperfused lungs. This suggests that O°is generated within the cell and enters the perfusate by transport across anion channels of cell membranes. Allopurinol decreased cytochrome c reduction during reperfusion, but the level of reduction was still higher than in nonreperfused lungs or lungs reperfused with SOD. Cytochrome c reduction was higher in lungs treated with deferoxamine than in untreated reperfused lungs. Cytochrome c reduction in DMTU-treated lungs was lower than in untreated reperfused lungs, but still higher than in uninjured lungs not reperfused or lungs reperfused with SOD.
Effects of anion channel blockade. The effect of anion channel blockade with DIDS on reperfusion lung injury is shown in Table II . The protective effect ofSOD on reperfusion lung injury is eliminated by anion channel blockade of lung cells with DIDS. In contrast, DIDS does not prevent allopurinol, an intracellular inhibitor of the generation of O°by xanthine oxidase, from protecting against reperfusion injury. 
Discussion
In our study, we have found that restoration of ventilation and perfusion to ischemic lungs results in pulmonary vasoconstriction and microvascular injury. The pulmonary vasoconstriction is likely due to generation ofcyclooxygenase products from AA, because increases in Pp,5 are prevented by the cyclooxygenase inhibitor indomethacin. Cyclooxygenase metabolites, specifically thromboxane, have been shown to mediate vasoconstriction in other models of oxidant lung injury in the rabbit (16, 31) . However, additional studies, including measurement of arachidonate products released during reperfusion, will be needed to clarify the role of arachidonate mediators in promoting reperfusion lung injury.
We have established that oxidant injury is the cause of pulmonary edema after reventilation and reperfusion by directly measuring enhanced O°generation in reperfused lung and by blocking reperfusion injury with accepted inhibitors of free radical-mediated reperfusion injury in other organs. Prevention of injury by pretreatment of lungs with SOD or catalase indicates that°2 and H202 are important in initiating injury. Blockade of injury with the iron chelator deferoxamine suggests that an iron-mediated Fenton reaction is necessary for toxicity to occur. While it is possible that deferoxamine was effective in part as a * OH scavenger (33) , the failure of ironsaturated deferoxamine to protect against injury points to a pivotal role of iron in reperfusion injury. Intracellular iron is normally bound as cofactor to enzymes or stored within the protein ferritin. However, there is a' rapid release of iron from ferritin under ischemic conditions (34) . It has also been shown recently that O°can directly mediate reductive release of iron from ferritin (35) . Free iron could, in turn, promote generation of * OH from H202 by the Fenton reaction. Whereas the Fenton mechanism is supported in our studies by the effectiveness of DMTU (18) or N-acetylcysteine (19) (12, 384 mol wt) molecule that detects only O2 released into the extracellular space, whereas NBT can be reduced intracellularly by metabolically active cells (21, 22) . Also, whereas both NBT (22) and ferricytochrome c (23) can be acted on by a number of competing reductase reactions, ferricytochrome c is much more specific for O2 (23) than is NBT (22) . Thus, we favor succinylated ferricytochrome c as a detector molecule for O2 in our model, even though it is less sensitive than NBT.
Despite the fact that they probably reflect events in different compartments, measurement of NBT (Fig. 7) and succinylated fernicytochrome c (Fig. 8) tase are responsible for much of the O2 normally produced by microsomes, and thus might be sources of O2 production during reperfusion injury (37) . In this regard, it is interesting to note that allopurinol is a known inhibitor of P-450 metabolism (38, 39) . Other potential microsomal sources of°2 are peroxidases associated with AA metabolism (40) , which have been hypothesized as sources of O°generated during reperfusion of ischemic brain (21) . Finally, O2 is a small but normal physiologic byproduct of aerobic mitochondrial metabolism at the NADH dehydrogenase step and from autooxidation of ubiquinone (41) . The rate of mitochondrial O2 production is directly proportional to 02 tension and inversely proportional to the respiratory rate of the cell, increasing under conditions of low ADP but high substrate and 02 availability when the respiratory rate is slow and components of the respiratory chain are mostly reduced (41) . These are the conditions that exist shortly after reperfusion of ischemic tissue, when substrate supply and 02 tension are restored, but ADP levels are low from catabolism during ischemia.
The mechanism whereby a large extracellular enzyme such as SOD (42) protects against reperfusion injury from intracellular generation of°2 is shown in Table II (43) . Reperfusion injury might play a role, as well, in acute pulmonary embolism, which could produce ischemia and subsequent reperfusion injury in the region of lung embolized. Also, reperfusion injury might be important as a magnification process for inflammation in the adult respiratory distress syndrome, in which perfusion of the pulmonary vasculature is occluded by vasoconstriction, microemboli, or in situ thromboses (44) . Finally, our findings might prove helpful in preventing postoperative pulmonary edema after lung and heart-lung transplantation (45) . If our success in preventing reperfusion injury in rabbit lungs can be applied to the design of an effective preservative solution, lung transplantation might become a more readily achievable therapeutic modality for patients with severe lung disease.
